Investor Overview

Webcast ImageWebcast
Celldex Therapeutics to present at Cowen and Company 30th Annual Health Care Conference (Replay)
03/10/10 at 11:00 a.m. ET
Celldex Therapeutics to present at Cowen and Company 30th Annual Health Care Conference
Wednesday, March 10, 2010 11:00 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Listen to the Webcast in Real Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Celldex Therapeutics is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex’s immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Quote
CLDX (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Price$5.36
Change (%) Stock is Down 0.04 (0.74%)
Volume396,570
Data as of 03/11/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
03/11/10Celldex Therapeutics to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference
NEEDHAM, Mass., Mar 11, 2010 (BUSINESS WIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex, will present onTuesday, March 16th, at 8:30 a.m. PDTat the 22nd Annual Roth Capital OC Growth Stock Conference taking place at The Ritz-Carlton, Laguna Niguel in Dana Point, CA. Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pi... 
Printer Friendly Version
03/08/10Celldex Therapeutics to Present at the Cowen & Company 30th Annual Health Care Conference
NEEDHAM, Mass., Mar 08, 2010 (BUSINESS WIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the 30th Annual Cowen & Company Health Care Conference at the Boston Marriott Copley Place on Wednesday, March 10, 2010 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the "Presentations" page of the "In... 
Printer Friendly Version
03/04/10Celldex Reports Fourth Quarter and Fiscal 2009 Financial Results
- Management to Host Conference Call to Discuss Results and Provide 2010 Outlook Today, Thursday, March 4, at 9:00 a.m. Eastern Time -NEEDHAM, Mass., Mar 04, 2010 (BUSINESS WIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the fourth quarter and year ended December 31, 2009. Celldex reported a net loss of $13.5 million, or $0.43 per share, for the fourth quarter of 2009 compared to a net loss of $7.5 million, or $0.47 per shar... 
Printer Friendly Version
02/25/10Celldex Therapeutics to Report Fourth-Quarter and Fiscal 2009 Financial Results and Provide Outlook for 2010 on March 4, 2010
- Conference Call to Follow at 9:00 am -NEEDHAM, Mass., Feb 25, 2010 (BUSINESS WIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX) will release its fourth quarter and fiscal 2009 financial results before U.S. financial markets open on Thursday, March 4, 2010. Celldex executives will host a conference call at 9:00 A.M. Eastern Time on the same day to provide a year-end summary for 2009 and an update on anticipated research and development and business object... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
03/16/10 8:30 a.m. PT
Celldex Therapeutics to present at Roth 22nd Annual Orange County Growth Conference
LocationLaguna Niguel, CA
What's New
Download Documentation 2008 Form 10-K
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Celldex Therapeutics, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.

Printer Friendly Version